Family affair
23 April, 2013 by Graeme O'NeillAssociate Professor Ruth Arkell is revealing the mysteries of the ZIC family of genes, which have been coordinating the development of the nervous system in vertebrate embryos for hundreds of millions of years.
AmpliPhi, Intrexon team for bacteriophage projects
19 April, 2013 by Dylan Bushell-EmblingAmpliPhi and synthetic biology company Intrexon will collaborate on bacteriophage treatments for antibiotic-resistant infections.
Fainting may run in the family
19 April, 2013Research shows that fainting may be genetically determined, providing a better understanding of this common condition
Celebrating art, science and cells
17 April, 2013Winning images of a cell biology image competition lit up Times Square in New York in April.
Pharmaxis names Brazil distributor for Bronchitol
10 April, 2013 by Dylan Bushell-EmblingPharmaxis (ASX:PXS) has tapped United Medical as its exclusive distribution partner and sales rep for cystic fibrosis treatment Bronchitol in Brazil.
Agricultural research receives funding
05 April, 2013Australian farmers are set to benefit from 31 new research projects that will look at adapting farming practices to reduce carbon emissions and earn them an income by generating and selling carbon credits.
New centre for biodiversity research
03 April, 2013CSIRO and the Australian National University have launched a new centre for biodiversity research.
The voice of reason
02 April, 2013 by Tim DeanProfessor Ian Chubb has used his considerable reach as Australia’s Chief Scientist to speak up for the importance of science on our future prosperity and wellbeing.
Superfast plant breeding
27 March, 2013A plant breeding project promises pure-line plant genotypes to increase food production.
Stay away from bats
26 March, 2013 by Susan WilliamsonAnother death in Australia from lyssavirus prompts experts to warn people to avoid contact with bats and flying foxes.
Leading immunologist visits Centenary Institute
18 March, 2013 by Susan WilliamsonProfessor Georg Melchers, from the University of Basel in Switzerland, is in Sydney to discuss biologics and the treatment of autoimmune diseases.
Mesoblast raises $170m for stem cell trials
14 March, 2013 by Dylan Bushell-EmblingMesoblast (ASX:MSB) has filled its coffers to the tune of $170m through a private placement in order to help raise funds for upcoming clinical trials of its adult stem cells.
Vaccine hope for Tasmanian devil facial tumour disease
13 March, 2013 by Susan WilliamsonAustralian researchers have taken part in an international study that has deciphered how devil facial tumour disease cells evade the immune system.
Cooperative research continues
12 March, 2013 by Susan WilliamsonThe 15th selection round for cooperative research centres will see the government spend $70 million on three new centres.
Pharmaxis completes Bronchitol trial
11 March, 2013 by Dylan Bushell-EmblingPharmaxis (ASX:PXS) shares climbed 15% after the company revealed it had completed a phase III trial of Bronchitol in patients with bronchiectasis.
